| [1] |
Obermiller P S,Tait D L,Holt J T.Gene therapy for carcinoma of the breast:therapeutic genetic correction strategies. Breast Cancer Res,2000,2:28 -31.
|
| [2] |
Soussi T.Focus on the p53 gene and cancer:advances in TP53 mutation research.Hum Mutat,2003,21:173 -175.
|
| [3] |
Ruley H E.p53 and response to chemotherapy and radiotherapy.Important Adv Oncol,1996:37 -56.
|
| [4] |
Kappler M,Tauber H,Bartel F,et al.Radiosensitization,after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line,but not in a mt-p53 sarcoma cell line. Oncol Rep,2005,13:167 -172.
|
| [5] |
Giovannetti E,Backus H H,Wouters D,et al. Changes in the status of p53 affect drug sensitivity to thymidylate synthase(TS) inhibitors by altering TS levels. Br J Cancer,2007,96:769 -775.
|
| [6] |
王亚红,孙玉兰,许少峰,等. 个体性反义RNA 对乳腺癌细胞突变p53 基因表达的特异性封闭作用.中华病理学杂志,2007,36:544 -549.
|
| [7] |
Vinyals A,Peinado M A,Gonzalez Garrigues M,et al.Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein.Gene Ther,1999,6:22 -33.
|
| [8] |
Willis A C,Chen X. The promise and obstacle of p53 as a cancer therapeutic agent.Curr Mol Med,2002,2:329 -345.
|
| [9] |
Zeimet A G,Riha K,Berger J, et al. New insights into p53 regulation and gene therapy for cancer. Biochem Pharmacol,2000,60:1153 -1163.
|
| [10] |
Cao J,Teng L,Cai X.Inhibition effect of p53 antisense RNA on malignant phenotype of colorectal cancer cells.Zhonghua Zhong Liu Za Zhi,1997,19:123 -126.
|
| [11] |
Toscano F,Parmentier B,Fajoui Z E,et al. p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells.Biochem Pharmacol,2007,74:392 -406.
|
| [12] |
王峰,束永前,王建华,等.腺病毒介导的野生型p53 基因对人肺腺癌细胞放射治疗敏感性的影响. 江苏大学学报,2006,16:427 -429.
|
| [13] |
朱光宇,卢勤,滕皋军,等. 经动脉导管注入脂质体介导的p53 基因治疗肝癌的实验研究. 介入放射学杂志,2007,12:109 -114.
|
| [14] |
Ndove A,Bouali S,Dolivet G,et al.Sustained gene transfer and enhanced cell death following glycosylated-PEI-mediated p53 gene transfer with photochemical internalisation in p53-mutated head and neck cancinoma cell. Int J Oncol, 2004, 25:1575-1581.
|